Kazakhstan's COVID-19 vaccine is among top 200 promising vaccines - The Washington Post
The Washington Post has included the COVID-19 vaccine, developed in Kazakhstan, in its list of 200 promising, experimental vaccines aimed at ending the pandemic, Strategy2050.kz reports.
According to the analysis published by The Washington Post, the coronavirus vaccine, developed by the Research Institute for Biological Safety Problems of Kazakhstan, is on the list of 200 experimental vaccines that will help defeat the global pandemic in the future.
The Washington Post has included Kazakhstan's vaccine in the category of weakened or inactivated virus vaccines, which take longer to manufacture, but this does not mean that this is reflected in the effectiveness of the vaccine.
According to The Washington Post, in a more old-fashioned approach, the virus is weakened so that it does not cause disease, but still triggers the immune system’s defenses. The vaccine for measles, mumps and rubella uses this approach.
Inactivated virus vaccines contain dead virus, incapable of infecting people but still able to instruct the immune system how to mount a defensive reaction against an infection. The polio vaccine invented by Jonas Salk used this approach, and flu vaccines use this technology.
The category of weakened or inactivated virus vaccines also includes vaccines developed by some Chinese research institutes and companies, India and Egypt.
The Washington Post reports that more than 170 COVID-19 vaccines are being tested in animals and lab experiments, 7 vaccines are being tested in a small number of healthy, young people to assess safety and correct dose, 12 vaccines are broadened to a larger group of people, including people at higher risk of illness and 7 vaccines are being tested in thousands of people to check their effectiveness and safety. Sadly, 0 vaccines have been determined to provide benefits that outweigh known and potential risks.
The worldwide effort to create a vaccine for the novel coronavirus kicked off in January, soon after scientists in China posted online the genome of a virus causing a mysterious pneumonia. Vaccine development usually takes years and unfolds step by step, but not with COVID-19. To date, the virus has already killed more than 813,000 people on the planet, according to an interactive map of Johns Hopkins University. That is why scientists from Kazakhstan and around the world are working tirelessly to find an "antidote" to the coronavirus infection, which not only takes human lives, but also destroys the economies of cities and entire countries.